Abbvie Inc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Abbvie Inc with three other
companies in this sector in UNITED STATES :
sales of $42.06 billion
of which 68%
Bristol-Myers Squibb Company
of which 30%
was Prioritized Brands-Eliquis), and
of which 38%
was Medical Devices).
During the year ended December of 2019, sales at
Abbvie Inc were $33.27 billion.
a very small
increase of 1.6%
versus 2018, when the company's sales were $32.75 billion.
This was the fifth consecutive year of sales increases at Abbvie Inc
(and since 2014, sales have increased a total of 67%).